Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.

The pharmaceutical company’s consolidated net loss reduced to Rs 24.49 crore in Q2 FY24 as against net loss of Rs 70.67 crore recorded in Q2 FY23. Revenue from operations rose 26.4% YoY to Rs 415.63 crore in Q2 FY24.

The counter hit a life-time high at Rs 479.25 in today’s intraday session.